[Therapeutic drug monitoring of antitumor agents].
Hoshi
A
A
National Cancer Center Research Institute, Chemotherapy Division.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid; D005455:Fluorescent Antibody Technique; D006207:Half-Life; D006801:Humans; D007124:Immunoenzyme Techniques; D011863:Radioimmunoassay; D013048:Specimen Handling
D000970:Antineoplastic Agents